← Leaderboards
Mitchell L Drumm
Case Western Reserve University
$12,943,746
Attributed
$14,078,542
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–19$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$21,684,558 · 18
By mechanism
P30$10,700,101 · 9
R01$5,798,487 · 3
R24$2,269,592 · 2
P01$1,570,184 · 1
P50$695,001 · 1
T32$651,193 · 2
Top collaborators
- Craig A Hodges5 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Kath Bogie$529
- Hongping Zhao$2,063,172
- Craig A Hodges$1,981,107
- Michael W. Konstan$52,389,820
- Mohan Sankaran$2,170,311
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisResearch PersonnelResourcesPhenotypeTissuesProgramsMouse ModelInterestLaboratory MouseInfectionTranslational ResearchCystic Fibrosis MouseTrainingAreaDatabasesAllelesDesignLiquid SubstanceChloride ChannelsCystic Fibrosis Transmembrane Conductance RegulatorResearch StudyGenesProceduresGenetic
Grant awards (54)
Pediatric Respiratory Research Training$146,502
T32 · FY2019 · HL · contact PI
Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.$531,182
P01 · FY2018 · HL · contact PI
Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.$531,182
P01 · FY2017 · HL · contact PI
Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.$507,820
P01 · FY2016 · HL · contact PI
Translational Research in Cystic Fibrosis$611,787
P30 · FY2014 · DK · contact PI
Animal Model Resources for Cystic Fibrosis$504,755
R24 · FY2014 · OD · contact PI
Administrative Component$305,894
P30 · FY2014 · DK · contact PI
Pilot and Feasibility$305,893
P30 · FY2014 · DK · contact PI
Administrative Supplement to Animal Model Resources for Cystic Fibrosis$193,833
R24 · FY2014 · OD · contact PI
Translational Research in Cystic Fibrosis$576,915
P30 · FY2013 · DK · contact PI
Animal Model Resources for Cystic Fibrosis$484,871
R24 · FY2013 · OD · contact PI
Administrative Component$206,042
P30 · FY2013 · DK · contact PI
Pilot and Feasibility$206,041
P30 · FY2013 · DK · contact PI
Mouse Models$82,416
P30 · FY2013 · DK · contact PI
Clinical$82,416
P30 · FY2013 · DK · contact PI
Translational Research in Cystic Fibrosis$627,832
P30 · FY2012 · DK · contact PI
Animal Model Resources for Cystic Fibrosis$525,734
R24 · FY2012 · OD · contact PI
Systems Biology Approach to Growth Regulation in Cystic Fibrosis$384,689
R01 · FY2012 · GM · contact PI
Research Base$125,578
P30 · FY2012 · DK · contact PI
Administrative Component$125,578
P30 · FY2012 · DK · contact PI
Pilot and Feasibility$125,577
P30 · FY2012 · DK · contact PI
Center Director$125,576
P30 · FY2012 · DK · contact PI
Enrichment Program$125,523
P30 · FY2012 · DK · contact PI
Translational Research in Cystic Fibrosis$1,122,350
P30 · FY2011 · DK · contact PI
Animal Model Resources for Cystic Fibrosis$560,399
R24 · FY2011 · RR · contact PI
Systems Biology Approach to Growth Regulation in Cystic Fibrosis$384,689
R01 · FY2011 · GM · contact PI
Animal Core$257,176
P30 · FY2011 · DK · contact PI
Translational Research in Cystic Fibrosis$1,122,350
P30 · FY2010 · DK · contact PI
Systems Biology Approach to Growth Regulation in Cystic Fibrosis$388,575
R01 · FY2010 · GM · contact PI
Animal Core$259,748
P30 · FY2010 · DK · contact PI
Translational Research in Cystic Fibrosis$1,122,350
P30 · FY2009 · DK · contact PI
Systems Biology Approach to Growth Regulation in Cystic Fibrosis$392,500
R01 · FY2009 · GM · contact PI
Animal Core$287,853
P30 · FY2009 · DK · contact PI
Translational Research in Cystic Fibrosis$114,111
P30 · FY2009 · DK · contact PI
Translational Research in Cystic Fibrosis$1,126,154
P30 · FY2008 · DK · contact PI
Animal Core$281,425
P30 · FY2008 · DK · contact PI
RESEARCH TRAINING PROGRAM PLAN$1
T32 · FY2008 · HL · contact PI
Translational Research in Cystic Fibrosis$1,182,167
P30 · FY2007 · DK · contact PI
RESEARCH TRAINING PROGRAM PLAN$504,690
T32 · FY2007 · HL · contact PI
Animal Core$191,349
P30 · FY2007 · DK · contact PI
Murine models to identify CF lung disease modifiers$662,888
R01 · FY2005 · HL
Murine models to identify CF lung disease modifiers$644,288
R01 · FY2004 · HL
Murine models to identify CF lung disease modifiers$626,229
R01 · FY2003 · HL
GENETICS OF MURINE AIRWAY SODIUM ABSORPTION: ROLE IN CF$267,750
R01 · FY2003 · HL
Murine models to identify CF lung disease modifiers$623,998
R01 · FY2002 · HL
GENETICS OF MURINE AIRWAY SODIUM ABSORPTION: ROLE IN CF$267,750
R01 · FY2002 · HL
MODIFIER GENES FOR CYSTIC FIBROSIS$263,865
P50 · FY2002 · HL
CORE--ANIMAL$0
P30 · FY2002 · DK
Murine models to identify CF lung disease modifiers$622,674
R01 · FY2001 · HL
GENETICS OF MURINE AIRWAY SODIUM ABSORPTION: ROLE IN CF$267,750
R01 · FY2001 · HL
MODIFIER GENES FOR CYSTIC FIBROSIS$263,865
P50 · FY2001 · HL
CORE--ANIMAL$0
P30 · FY2001 · DK
GENETICS OF MURINE AIRWAY SODIUM ABSORPTION: ROLE IN CF$264,707
R01 · FY2000 · HL
MODIFIER GENES FOR CYSTIC FIBROSIS$167,271
P50 · FY2000 · HL